These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33569141)

  • 1. Redefining Therapeutic Outcomes of Depression Treatment.
    Slofstra C; Booij SH; Rogier Hoenders HJ; Castelein S
    J Pers Oriented Res; 2019; 5(2):1-8. PubMed ID: 33569141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i).
    Bastiaansen JA; Meurs M; Stelwagen R; Wunderink L; Schoevers RA; Wichers M; Oldehinkel AJ
    BMC Psychiatry; 2018 Sep; 18(1):276. PubMed ID: 30176845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial to evaluate the effects of personalized prediction and adaptation tools on treatment outcome in outpatient psychotherapy: study protocol.
    Lutz W; Zimmermann D; Müller VNLS; Deisenhofer AK; Rubel JA
    BMC Psychiatry; 2017 Aug; 17(1):306. PubMed ID: 28836954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining and measuring functional recovery from depression.
    Greer TL; Kurian BT; Trivedi MH
    CNS Drugs; 2010 Apr; 24(4):267-84. PubMed ID: 20297853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical judgement, case complexity and symptom scores as predictors of outcome in depression: an exploratory analysis.
    Smith M; Francq B; McConnachie A; Wetherall K; Pelosi A; Morrison J
    BMC Psychiatry; 2020 Mar; 20(1):125. PubMed ID: 32183799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized therapy with TNF-inhibitors in Crohn's disease: optimizing treatment outcomes by monitoring drug levels and anti-drug antibodies.
    Steenholdt C
    Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing multifactorial psychotherapy research in online virtual environments (IMPROVE-2): study protocol for a phase III trial of the MOST randomized component selection method for internet cognitive-behavioural therapy for depression.
    Watkins E; Newbold A; Tester-Jones M; Javaid M; Cadman J; Collins LM; Graham J; Mostazir M
    BMC Psychiatry; 2016 Oct; 16(1):345. PubMed ID: 27716200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of nonpharmacological interventions in older adults with depressive disorders: a systematic review.
    Apóstolo J; Queirós P; Rodrigues M; Castro I; Cardoso D
    JBI Database System Rev Implement Rep; 2015 Jul; 13(6):220-78. PubMed ID: 26455753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of 1-year outcome in depression.
    Parker G; Wilhelm K; Mitchell P; Gladstone G
    Aust N Z J Psychiatry; 2000 Feb; 34(1):56-64. PubMed ID: 11185945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the Personalized Advantage Index for Individual Treatment Allocation to Blended Treatment or Treatment as Usual for Depression in Secondary Care.
    Friedl N; Krieger T; Chevreul K; Hazo JB; Holtzmann J; Hoogendoorn M; Kleiboer A; Mathiasen K; Urech A; Riper H; Berger T
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32054084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Medicine in the Context of Comparative Effectiveness Research.
    Basu A
    Forum Health Econ Policy; 2013 Sep; 16(2):S73-S86. PubMed ID: 31419872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and predictors of late-life depression trajectories in older primary care patients.
    Cui X; Lyness JM; Tang W; Tu X; Conwell Y
    Am J Geriatr Psychiatry; 2008 May; 16(5):406-15. PubMed ID: 18448851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abandoning personalization to get to precision in the pharmacotherapy of depression.
    Perlis RH
    World Psychiatry; 2016 Oct; 15(3):228-235. PubMed ID: 27717262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.
    Amare AT; Schubert KO; Baune BT
    EPMA J; 2017 Sep; 8(3):211-227. PubMed ID: 29021832
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.